What the Options Market Tells Us About Viking Therapeutics
What the Options Market Tells Us About Viking Therapeutics
Deep-pocketed investors have adopted a bullish approach towards Viking Therapeutics (NASDAQ:VKTX), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in VKTX usually suggests something big is about to happen.
有實力的投資者對viking therapeutics(NASDAQ:VKTX)採取了看好的態度，這對市場參與者來說是一件不能忽視的事情。我們在Benzinga的公共期權記錄中發現了這一重大舉動。這些投資者的身份尚不清楚，但VKTX的這一大規模動作通常意味着即將發生重大變化。
We gleaned this information from our observations today when Benzinga's options scanner highlighted 19 extraordinary options activities for Viking Therapeutics. This level of activity is out of the ordinary.
我們從今天Benzinga的期權掃描器突出顯示的19次異常期權活動中得到了這一信息。這種活動水平是非同尋常的。
The general mood among these heavyweight investors is divided, with 57% leaning bullish and 26% bearish. Among these notable options, 2 are puts, totaling $68,050, and 17 are calls, amounting to $1,797,218.
這些重量級投資者之間的整體情緒是分歧的，57%傾向於看漲而26%看淡。在這些顯著的期權中，有2個看跌，總計68,050美元，還有17個看漲，總計1,797,218美元。
Projected Price Targets
預計價格目標
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $30.0 and $100.0 for Viking Therapeutics, spanning the last three months.
在評估交易量和持倉量後，顯然市場主導者關注的是viking therapeutics在30.0美元至100.0美元之間的價格區間，跨越過去三個月。
Volume & Open Interest Development
成交量和持倉量的評估是期權交易中的一個關鍵步驟。這些指標揭示了阿里巴巴集團（Alibaba Gr Hldgs）特定執行價格期權的流動性和投資者興趣。下面的數據可視化了在過去30天內，阿里巴巴集團（Alibaba Gr Hldgs）在執行價格在74.0美元到120.0美元區間內的看漲看跌期權中，成交量和持倉量的波動情況。
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Viking Therapeutics's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Viking Therapeutics's substantial trades, within a strike price spectrum from $30.0 to $100.0 over the preceding 30 days.
評估交易量和持倉量是期權交易的戰略步驟。這些指標揭示了viking therapeutics期權在指定行權價上的流動性和投資者的興趣。即將發佈的數據可視化了在過去30天內viking therapeutics在30.0美元至100.0美元的行權價光譜上，涉及看漲和看跌期權的交易波動。
Viking Therapeutics Option Volume And Open Interest Over Last 30 Days
Viking Therapeutics過去30天內期權成交量和未平倉合約變化情況
Biggest Options Spotted:
最大的期權交易：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| VKTX | CALL | SWEEP | BULLISH | 01/17/25 | $35.5 | $34.2 | $35.5 | $30.00 | $177.5K | 1.9K | 350 |
| VKTX | CALL | TRADE | BULLISH | 01/17/25 | $35.5 | $34.2 | $35.5 | $30.00 | $177.5K | 1.9K | 250 |
| VKTX | CALL | TRADE | BULLISH | 01/17/25 | $36.3 | $34.2 | $35.5 | $30.00 | $177.5K | 1.9K | 250 |
| VKTX | CALL | TRADE | BULLISH | 01/17/25 | $36.1 | $34.0 | $35.5 | $30.00 | $177.5K | 1.9K | 200 |
| VKTX | CALL | SWEEP | BULLISH | 01/17/25 | $35.5 | $34.0 | $35.5 | $30.00 | $177.5K | 1.9K | 150 |
| 標的 | 看跌/看漲 | 交易類型 | 情緒 | 到期日 | 賣盤 | 買盤 | 價格 | 執行價格 | 總交易價格 | 未平倉合約數量 | 成交量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| VKTX | 看漲 | SWEEP | 看好 | 01/17/25 | $35.5 | 34.2美元 | $35.5 | $30.00 | $177.5K | 1.9K | 350 |
| VKTX | 看漲 | 交易 | 看好 | 01/17/25 | $35.5 | 34.2美元 | $35.5 | $30.00 | $177.5K | 1.9K | 250 |
| VKTX | 看漲 | 交易 | 看好 | 01/17/25 | $36.3 | 34.2美元 | $35.5 | $30.00 | $177.5K | 1.9K | 250 |
| VKTX | 看漲 | 交易 | 看好 | 01/17/25 | $36.1 | 34.0美元 | $35.5 | $30.00 | $177.5K | 1.9K | 200 |
| VKTX | 看漲 | SWEEP | 看好 | 01/17/25 | $35.5 | 34.0美元 | $35.5 | $30.00 | $177.5K | 1.9K | 150 |
About Viking Therapeutics
關於Viking Therapeutics
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
Viking Therapeutics Inc是一家衛生服務提供商，專門從事代謝和內分泌障礙領域的生物製藥開發。該公司的臨床項目流水線包括VK2809、VK5211、VK0214產品。VK2809和VK0214是口服、組織和受體亞型選擇性的甲狀腺激素受體β激動劑。VK5211是一種口服、非類固醇選擇性雄激素受體調節劑。
Following our analysis of the options activities associated with Viking Therapeutics, we pivot to a closer look at the company's own performance.
在分析與Viking Therapeutics相關的期權交易活動後，我們轉而更近距離地關注該公司的業績表現。
Where Is Viking Therapeutics Standing Right Now?
Viking Therapeutics現狀如何？
- Currently trading with a volume of 2,479,687, the VKTX's price is down by -5.63%, now at $63.32.
- RSI readings suggest the stock is currently is currently neutral between overbought and oversold.
- Anticipated earnings release is in 36 days.
- viking therapeutics目前成交量爲2479687，價格下跌了-5.63%，目前報$63.32。
- RSI讀數表明該股票目前處於中立狀態，處於超買和超賣之間。
- 預計的收益發布還有36天。
Professional Analyst Ratings for Viking Therapeutics
Viking Therapeutics的專業分析師評級
In the last month, 2 experts released ratings on this stock with an average target price of $92.5.
在過去的一個月裏，2位專家對該股票進行了評級，平均目標價格爲$92.5。
- An analyst from Morgan Stanley downgraded its action to Overweight with a price target of $105.
- An analyst from JP Morgan has revised its rating downward to Overweight, adjusting the price target to $80.
- 摩根士丹利的分析師將其行動下調爲超配，目標價格爲$105。
- JP摩根的一位分析師下調了評級至增持，調低了價格目標至80美元。
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Viking Therapeutics with Benzinga Pro for real-time alerts.
交易期權涉及更大的風險，但也提供了更高的利潤潛力。精明的交易者通過持續教育、戰略性的交易調整、利用各種因子和保持市場動態來減輕這些風險。使用Benzinga Pro即可了解Viking Therapeutics的最新期權交易情況，並獲取實時警報。
譯文內容由第三人軟體翻譯。